These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 31864836)

  • 1. Corrigendum to "Downregulation of long noncoding RNA HCP5 contributes to cisplatin resistance in human triple-negative breast cancer via regulation of PTEN expression" [Biomed. Pharmacother. 115 (2019) 108869].
    Wu J; Chen H; Ye M; Wang B; Zhang Y; Sheng J; Meng T; Chen H
    Biomed Pharmacother; 2020 Feb; 122():109789. PubMed ID: 31864836
    [No Abstract]   [Full Text] [Related]  

  • 2. Long noncoding RNA HCP5 contributes to cisplatin resistance in human triple-negative breast cancer via regulation of PTEN expression.
    Wu J; Chen H; Ye M; Wang B; Zhang Y; Sheng J; Meng T; Chen H
    Biomed Pharmacother; 2019 Jul; 115():108869. PubMed ID: 31028999
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Corrigendum to "Linc00152 promotes tumorigenesis by regulating DNMTs in triple-negative breast cancer" [Biomed Pharmacother. 97 (2018) 1275-1281].
    Wu J; Shuang Z; Zhao J; Tang H; Liu P; Zhang L; Xie X; Xiao X
    Biomed Pharmacother; 2020 Jul; 127():110174. PubMed ID: 32423656
    [No Abstract]   [Full Text] [Related]  

  • 4. Corrigendum to "Schisandrin A inhibits triple negative breast cancer cells by regulating Wnt/ER stress signaling pathway" [Biomed. Pharmacother. 115 (2019) 108922].
    Xu X; Rajamanicham V; Xu S; Liu Z; Yan T; Liang G; Guo G; Zhou H; Wang Y
    Biomed Pharmacother; 2022 May; 149():112865. PubMed ID: 35367116
    [No Abstract]   [Full Text] [Related]  

  • 5. Corrigendum to "Cellular landscaping of cisplatin resistance in cervical cancer" Biomed. Pharmacother. 153(2022) 113345.
    Bhattacharjee R; Dey T; Kumar L; Kar S; Sarkar R; Ghorai M; Malik S; Jha NK; Vellingiri B; Kesari KK; Pérez de la Lastra JM; Dey A
    Biomed Pharmacother; 2024 Aug; 177():117097. PubMed ID: 38964956
    [No Abstract]   [Full Text] [Related]  

  • 6. Corrigendum to "MiR-25-3p promotes malignant phenotypes of retinoblastoma by regulating PTEN/Akt pathway" [Biomed. Pharmacother. 118 (2019) 109111].
    Wan W; Wan W; Long Y; Li Q; Jin X; Wan G; Zhang F; Lv Y; Zheng G; Li Z; Zhu Y
    Biomed Pharmacother; 2020 Nov; 131():110842. PubMed ID: 33092949
    [No Abstract]   [Full Text] [Related]  

  • 7. Corrigendum to "Herb-drug interaction: A case study of effects and involved mechanisms of cisplatin on the pharmacokinetics of ginsenoside Rb1 in tumor-bearing mice" [Biomed. Pharmacother. 110 (2019) 95-104].
    Zhou J; Wu J; Wu CY; Long F; Shen H; Zhang W; Li SL
    Biomed Pharmacother; 2019 Jun; 114():108827. PubMed ID: 30954310
    [No Abstract]   [Full Text] [Related]  

  • 8. Valproic Acid Promotes Apoptosis and Cisplatin Sensitivity Through Downregulation of H19 Noncoding RNA in Ovarian A2780 Cells.
    Sajadpoor Z; Amini-Farsani Z; Teimori H; Shamsara M; Sangtarash MH; Ghasemi-Dehkordi P; Yadollahi F
    Appl Biochem Biotechnol; 2018 Aug; 185(4):1132-1144. PubMed ID: 29468525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Corrigendum to "Huachansu capsule inhibits the proliferation of human gastric cancer cells via Akt/mTOR pathway" [Biomed. Pharmacother. 118 (2019) 109241].
    Ni T; Wang H; Li D; Tao L; Lv M; Jin F; Wang W; Feng J; Qian Y; Sunagawa M; Liu Y
    Biomed Pharmacother; 2020 Mar; 123():109823. PubMed ID: 31959384
    [No Abstract]   [Full Text] [Related]  

  • 10. Corrigendum to "Triptolide inhibits the migration and invasion of human prostate cancer cells via Caveolin-1/CD147/MMPs pathway" [Biomed. Pharmacother. 84 (2016) 1776-1782].
    Yuan S; Wang L; Chen X; Fan B; Yuan Q; Zhang H; Yang D; Wang S
    Biomed Pharmacother; 2020 Feb; 122():109782. PubMed ID: 31862132
    [No Abstract]   [Full Text] [Related]  

  • 11. Corrigendum to "Carnitine/organic cation transporter 2 (OCTN2) contributes to rat epididymal epithelial cell growth and proliferation" [Biomed. Pharmacother. 93(2017):444-450].
    Li D; Liu J; Wei D; Liu H; Xiao W; Song X; Fan Z; Ke C; Qiangguo Y; Qin W; Tang Y; Xiaoyong P
    Biomed Pharmacother; 2018 Aug; 104():854. PubMed ID: 29753602
    [No Abstract]   [Full Text] [Related]  

  • 12. Corrigendum to "XIAOPI formula promotes breast cancer chemosensitivity via inhibiting CXCL1/HMGB1-mediated autophagy" [Biomed. Pharmacother. 120 (2019) 109519].
    Wang N; Yang B; Muhetaer G; Wang S; Zheng Y; Lu J; Li M; Zhang F; Situ H; Lin Y; Wang Z
    Biomed Pharmacother; 2022 May; 149():112867. PubMed ID: 35370022
    [No Abstract]   [Full Text] [Related]  

  • 13. Long non-coding RNA TUG1 sponges miR-197 to enhance cisplatin sensitivity in triple negative breast cancer.
    Tang T; Cheng Y; She Q; Jiang Y; Chen Y; Yang W; Li Y
    Biomed Pharmacother; 2018 Nov; 107():338-346. PubMed ID: 30098551
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LncRNA HCP5 promotes the development of cervical cancer by regulating MACC1 via suppression of microRNA-15a.
    Yu Y; Shen HM; Fang DM; Meng QJ; Xin YH
    Eur Rev Med Pharmacol Sci; 2018 Aug; 22(15):4812-4819. PubMed ID: 30070314
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Knockdown of HCP5 exerts tumor-suppressive functions by up-regulating tumor suppressor miR-128-3p in anaplastic thyroid cancer.
    Chen J; Zhao D; Meng Q
    Biomed Pharmacother; 2019 Aug; 116():108966. PubMed ID: 31102936
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Corrigendum to "A nuclear targeted Dox-aptamer loaded liposome delivery platform for the circumvention of drug resistance in breast cancer" [Biomed. Pharmacother. 117 (2019) 109072].
    Li X; Wu X; Yang H; Li L; Ye Z; Rao Y
    Biomed Pharmacother; 2023 Sep; 165():115182. PubMed ID: 37474405
    [No Abstract]   [Full Text] [Related]  

  • 17. Corrigendum to "Cryptotanshinone induces melanoma cancer cells apoptosis via ROS-mitochondrial apoptotic pathway and impairs cell migration and invasion" [Biomed. Pharmacother. 82 (2016) 319-326].
    Ye T; Zhu S; Zhu Y; Feng Q; He B; Xiong Y; Zhao L; Zhang Y; Yu L; Yang L
    Biomed Pharmacother; 2019 Dec; 120():109510. PubMed ID: 31635901
    [No Abstract]   [Full Text] [Related]  

  • 18. Corrigendum to "Ginsenoside Rd contributes the attenuation of cardiac hypertrophy in vivo and in vitro" [Biomed. Pharmacother. 109 (2019) 1016-1023].
    Zhang N; An X; Lang P; Wang F; Xie Y
    Biomed Pharmacother; 2020 Oct; 130():110720. PubMed ID: 34321161
    [No Abstract]   [Full Text] [Related]  

  • 19. Corrigendum to 'Metapristone suppresses non-small cell lung cancer proliferation and metastasis via modulating RAS/RAF/MEK/MAPK signaling pathway' [Biomed. Pharmacother. 90 (2017) 437-445].
    Zheng G; Shen Z; Chen H; Liu J; Jiang K; Fan L; Jia L; Shao J
    Biomed Pharmacother; 2018 Feb; 98():925-926. PubMed ID: 29421862
    [No Abstract]   [Full Text] [Related]  

  • 20. Retraction notice to "Long noncoding RNA maternally expressed gene 3 knockdown alleviates lipopolysaccharide induced inflammatory injury by up-regulation of miR-203 in ATDC5 cells" [Biomed. Pharmacother. 100 (2018) 240-249].
    Wang Z; Chi X; Liu L; Wang Y; Mei X; Yang Y; Jia T
    Biomed Pharmacother; 2021 Oct; 142():112099. PubMed ID: 34507836
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.